NOVARTIS AG (NVSEF)
Clinical trial NCT06335979 updates: 1. completion date: 2027-07-09 → 2027-11-17 2. primary completion date: 2027-07-09 → 2027-11-17 3. enrollment: not set → 54 participants
Clinical trial NCT06335979 updates: 1. completion date: 2027-07-09 → 2027-11-17 2. primary completion date: 2027-07-09 → 2027-11-17 3. enrollment: not set → 54 participants
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical